NasdaqCM - Nasdaq Real Time Price USD
NeuroOne Medical Technologies Corporation (NMTC)
0.6500
+0.0126
+(1.98%)
As of 3:40:15 PM EDT. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
5,749.5210
3,453.0030
1,952.4410
171.1690
178.1460
Cost of Revenue
3,009.2790
2,373.3360
1,495.9240
241.9630
275.8950
Gross Profit
2,740.2420
1,079.6670
456.5170
-70.7940
-97.7490
Operating Expense
9,525.7690
12,966.8760
12,411.7670
9,959.9710
10,120.4620
Operating Income
-6,785.5270
-11,887.2090
-11,955.2500
-10,030.7650
-10,218.2110
Net Non Operating Interest Income Expense
-553.7260
-228.9880
--
--
-3.0530
Other Income Expense
151.3650
-201.9130
95.7590
31.1520
273.0960
Pretax Income
-7,187.8880
-12,318.1100
-11,859.4910
-9,999.6130
-9,948.1680
Net Income Common Stockholders
-7,187.8880
-12,318.1100
-11,859.4910
-9,999.6130
-9,948.1680
Diluted NI Available to Com Stockholders
-7,187.8880
-12,318.1100
-11,859.4910
-9,999.6130
-9,948.1680
Basic EPS
-0.26
-0.46
-0.65
-0.63
-0.93
Diluted EPS
-0.26
-0.46
-0.65
-0.63
-0.93
Basic Average Shares
28,472.8700
26,762.3920
18,121.1080
15,998.5670
10,696.7990
Diluted Average Shares
28,483.5930
26,762.3920
18,121.1080
15,998.5670
10,696.7990
Total Operating Income as Reported
-6,785.5270
-11,887.2090
-11,955.2500
-10,030.7650
-10,218.2110
Total Expenses
12,535.0480
15,340.2120
13,907.6910
10,201.9340
10,396.3570
Net Income from Continuing & Discontinued Operation
-7,187.8880
-12,318.1100
-11,859.4910
-9,999.6130
-9,948.1680
Normalized Income
-7,250.2410
-11,991.0180
-11,859.4910
-9,999.6130
-9,950.1420
Interest Expense
553.7260
228.9880
--
--
3.0530
Net Interest Income
-553.7260
-228.9880
--
--
-3.0530
EBIT
-6,634.1620
-12,089.1220
-11,859.4910
-10,030.7650
-9,945.1150
EBITDA
-6,380.9010
-11,842.3310
-11,660.2250
-9,912.1450
-9,864.3670
Reconciled Cost of Revenue
3,009.2790
2,373.3360
1,495.9240
241.9630
275.8950
Reconciled Depreciation
253.2610
246.7910
199.2660
118.6200
80.7480
Net Income from Continuing Operation Net Minority Interest
-7,187.8880
-12,318.1100
-11,859.4910
-9,999.6130
-9,948.1680
Total Unusual Items Excluding Goodwill
62.3530
-327.0920
--
--
1.9740
Total Unusual Items
62.3530
-327.0920
--
--
1.9740
Normalized EBITDA
-6,443.2540
-11,515.2390
-11,660.2250
-9,912.1450
-9,866.3410
9/30/2021 - 3/15/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VTAK Catheter Precision, Inc.
0.2774
+0.18%
MODD Modular Medical, Inc.
1.0500
+5.00%
IRIX IRIDEX Corporation
1.1603
+0.90%
NUWE Nuwellis, Inc.
0.9120
-10.59%
MDAI Spectral AI, Inc.
1.1900
-4.03%
VNRX VolitionRx Limited
0.5067
+1.29%
QTIH QT Imaging Holdings, Inc.
0.8700
+3.51%
AXDX Accelerate Diagnostics, Inc.
0.4800
-14.29%
BSGM BioSig Technologies, Inc.
1.4580
+0.56%
PAVM PAVmed Inc.
0.7700
0.00%